Evommune Inc
Evommune Inc (EVMN) Covered Calls
No qualifying covered call setups were found for EVMN in the prior session.
Read more
Running EVMN covered calls helps you generate consistent income from Evommune Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Evommune Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best EVMN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if EVMN stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling EVMN covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Evommune Inc covered call is worth writing.
Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC).
Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Income-focused investors, long-term EVMN holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling EVMN covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Evommune Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)189
- 52 weeks high-84.31%
- 52 weeks low2.36%
- Analyst recommendationBuy
1.54 - Target price$22.40
329.94% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-08-06
- P/E—
- Future P/E—
- EPS (ttm)-2.83
- EPS growth next 5 years32.93%
As of October 21, 2026
No illustrative rows to display.
As of October 21, 2026
Sell covered calls with the data behind you
Find the best EVMN covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→